publicaciones seleccionadas
-
documento
- PiRNAs y proteínas PIWI-like como nuevos biomarcadores en cáncer 2024-06-30
- Utilidad diagnóstica y pronóstica de la clasificación molecular en gliomas de alto grado 2024-03-10
- Mutaciones en los genes PIK3c2B, ERBB3, KIT y MLH1 se correlaciona con la resistencia al uso de temozolomida en pacientes con gliomas de alto grado 2023-07-13
- Mutaciones en los genes PDGFRA, KIT y KDR en pacientes con glioblastoma se relacionan con un peor desenlace 2023-04-10
- Búsqueda de nuevos biomarcadores genéticos en gliomas de alto grado 2020-02-26
- A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma 2019-10
- Citometría de flujo en reticulocitos de sangre periférica como indicador de inestabilidad cromosómica en pacientes con gliomas de alto grado 2018-09-01
- 65 YEARS OF THE DOUBLE HELIX: Treatment of pituitary tumors with temozolomide: an update 2018-08
- Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016 2018-03
- Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma 2018-01
- Genotyping low-grade gliomas among Hispanics 2016-09-01
- BI-05 * MOLECULAR PROFILING OF LOW GRADE GLIOMAS (LGG) IN COLOMBIA (ONCOLGROUP) 2014-11-01
- Anti-VEGF therapy in pituitary carcinoma 2012-09
- Non-uniform Response to Temozolomide Therapy in a Pituitary Gonadotroph Adenoma 2012-09
- Pituitary tumors in patients with MEN1 syndrome 2012-04
- Temozolomide in aggressive pituitary adenomas and carcinomas 2012-04
- Stem Cells in Brain Tumorigenesis and their Impact on Therapy 2011-12-01
- Undifferentiated Sarcoma of the Sellar Region 2011-09
- Aggressive silent corticotroph adenoma progressing to pituitary carcinoma. The role of temozolomide therapy 2011-04-15
- Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma 2009-10-15
- MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy 2008-02
- Erratum to “Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: morphological findings” 2007-03
- Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: morphological findings 2007-01
- Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm 2006-10